“The tuberin-hamartin complex negatively regulates beta-catenin signaling activity”. The Journal of Biological Chemistry278 (8): 5947–51. (February 2003). doi:10.1074/jbc.C200473200. PMID12511557.
“Interaction of FoxO1 and TSC2 induces insulin resistance through activation of the mammalian target of rapamycin/p70 S6K pathway”. The Journal of Biological Chemistry281 (52): 40242–51. (December 2006). doi:10.1074/jbc.M608116200. PMID17077083.
“TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth”. Cell126 (5): 955–68. (September 2006). doi:10.1016/j.cell.2006.06.055. PMID16959574.
“Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis”. Cell121 (2): 179–93. (April 2005). doi:10.1016/j.cell.2005.02.031. PMID15851026.
“Association of focal adhesion kinase with tuberous sclerosis complex 2 in the regulation of s6 kinase activation and cell growth”. The Journal of Biological Chemistry281 (49): 37321–9. (December 2006). doi:10.1074/jbc.M605241200. PMID17043358.
“Pam and its ortholog highwire interact with and may negatively regulate the TSC1.TSC2 complex”. The Journal of Biological Chemistry279 (2): 1351–8. (January 2004). doi:10.1074/jbc.M310208200. PMID14559897.
“Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner”. The Journal of Biological Chemistry278 (35): 32493–6. (August 2003). doi:10.1074/jbc.C300226200. PMID12842888.
“Multicompartmental distribution of the tuberous sclerosis gene products, hamartin and tuberin”. Archives of Biochemistry and Biophysics404 (2): 210–7. (August 2002). doi:10.1016/S0003-9861(02)00300-4. PMID12147258.
“Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins”. Nature Cell Biology5 (6): 578–81. (June 2003). doi:10.1038/ncb999. PMID12771962.
“Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin”. The Journal of Biological Chemistry279 (34): 35664–70. (August 2004). doi:10.1074/jbc.M403385200. PMID15175323.
“Identification and characterization of the interaction between tuberin and 14-3-3zeta”. The Journal of Biological Chemistry277 (42): 39417–24. (October 2002). doi:10.1074/jbc.M204802200. PMID12176984.
“The tuberin-hamartin complex negatively regulates beta-catenin signaling activity”. The Journal of Biological Chemistry278 (8): 5947–51. (February 2003). doi:10.1074/jbc.C200473200. PMID12511557.
“Interaction of FoxO1 and TSC2 induces insulin resistance through activation of the mammalian target of rapamycin/p70 S6K pathway”. The Journal of Biological Chemistry281 (52): 40242–51. (December 2006). doi:10.1074/jbc.M608116200. PMID17077083.
“TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth”. Cell126 (5): 955–68. (September 2006). doi:10.1016/j.cell.2006.06.055. PMID16959574.
“Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis”. Cell121 (2): 179–93. (April 2005). doi:10.1016/j.cell.2005.02.031. PMID15851026.
“Association of focal adhesion kinase with tuberous sclerosis complex 2 in the regulation of s6 kinase activation and cell growth”. The Journal of Biological Chemistry281 (49): 37321–9. (December 2006). doi:10.1074/jbc.M605241200. PMID17043358.
“Pam and its ortholog highwire interact with and may negatively regulate the TSC1.TSC2 complex”. The Journal of Biological Chemistry279 (2): 1351–8. (January 2004). doi:10.1074/jbc.M310208200. PMID14559897.
“Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner”. The Journal of Biological Chemistry278 (35): 32493–6. (August 2003). doi:10.1074/jbc.C300226200. PMID12842888.
“Multicompartmental distribution of the tuberous sclerosis gene products, hamartin and tuberin”. Archives of Biochemistry and Biophysics404 (2): 210–7. (August 2002). doi:10.1016/S0003-9861(02)00300-4. PMID12147258.
“Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins”. Nature Cell Biology5 (6): 578–81. (June 2003). doi:10.1038/ncb999. PMID12771962.
“Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin”. The Journal of Biological Chemistry279 (34): 35664–70. (August 2004). doi:10.1074/jbc.M403385200. PMID15175323.
“Identification and characterization of the interaction between tuberin and 14-3-3zeta”. The Journal of Biological Chemistry277 (42): 39417–24. (October 2002). doi:10.1074/jbc.M204802200. PMID12176984.